why choose us

First received: November 11, 2022

Clinical Trial: CAR T Cells in Mesothelin-Expressing Breast Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Breast Cancer

Study Type: INTERVENTIONAL


Official Title: Phase 1, Adaptive-design Trial of Human Chimeric Antigen Receptor Modified T Cells in Patients With Mesothelin Expressing Breast Cancer

Brief Summary: Phase 1 - Safety and Proof of Concept

Read more